Indian Government In Dilemma As DCGI's Competence Is Questioned Amid Mounting Criticism
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - An eerie uncertainty looms over the future of India's highest and most powerful drug authority, the Drug Controller General of India, as the government was challenged last week against its decision to grant a nine-month service term extension to the present incumbent Surinder Singh